Paediatric heart failure - understanding the pathophysiology and the current role of cardiac biomarkers in clinical practice.

Further large paediatric studies of patients with heart failure are needed to validate NT-proBNP in CHD and to evaluate the role of novel biomarkers in specific types of CHD, e.g. single ventricle physiology.